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TITLE 
The role of scientific self-regulation for the control of genome editing in the human 
germline 5 
The lessons from the Asilomar and the Napa meetings show how self-regulation and public 
deliberation can lead to regulation of new biotechnologies  
 
By Daniel Gregorowius, Nikola Biller-Andorno, Anna Deplazes-Zemp* 
 10 
CRISPR-Cas9-based gene editing technology has fuelled a debate about the implications 
resulting from the new possibility of genome editing in the human germline [1,2]. Scientists 
have suggested how this technology could be regulated and evaluated to prevent misuse or 
abuse. Such discussions amongst scientists are not new: in the early days of recombinant 
DNA technology, scientists called attention to the potential benefits and risks of this new tool 15 
to genetically modifying living organisms. This development led to the famous conference 
held at Asilomar State Beach in California, in 1975. Forty years later, scientists and experts 
from ethics and law convened in Napa Valley, California, to discuss the scientific, societal 
and ethical implications of applying genome editing technologies in the human germline. The 
Napa group explicitly regarded their meeting as being in the tradition of Asilomar, to discuss 20 
guidelines and self-regulation for biotechnological developments.  
 
Emerging technologies in biomedical research often touch on ethical and societal questions 
that cannot be answered by scientists alone. Thus, the inclusion of other experts in discussions 
about regulation as well as public engagement [3] has become increasingly important in order 25 
to take into account the wide spectrum of implications; and for maintaining public confidence 
in the regulatory instruments to control the use of novel technologies. Here, we discuss the 
opportunities and limitations of self-regulation for emerging biotechnologies based on a 
comparison of the Asilomar conference and the Napa meeting and propose a model that 
combines self-regulation with national and international governance in the context of using 30 
gene-editing technologies in the human germline. 
 
From Asilomar to Napa 
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The paradigm case of scientific self-regulation in the biosciences is the above-mentioned 
"Asilomar Conference on Recombinant DNA," which was held after restriction enzymes and 
their application for genetically manipulating bacteria were discovered. Some molecular 
biologists, who at the time were concerned about the potential risks particularly for human 
health, convinced their colleagues to adhere to a voluntary moratorium on certain experiments 5 
until strategies to reduce such risks or prevent potential hazards were developed [4]. After 
many controversial debates before and during the conference, the attendees finally reached a 
consensus on safety issues and published recommendations on how to regulate this new 
technology. These recommendations formed the basis for the US National Institutes of 
Health's (NIH) "Guidelines for Research Involving Recombinant DNA Molecules" in the 10 
USA and subsequently influenced regulations in Europe. The Asilomar conference illustrates 
how the scientific community can effectively impose a moratorium on certain types of 
experiments and how a process of self-regulation in science can lead to guidelines for the safe 
handling of new biotechnologies. Given that the objective was to find technical solutions to 
address concerns about health risks, self-regulation seems reasonable, because scientists have 15 
expert knowledge pertaining to the potential risks and side effects of their research. The 
scientists did not, however, decide which risks were acceptable or not – this is not a scientific 
question, but a normative one. 
 
Forty years after Asilomar, the scientific community convened again to discuss the risks of 20 
new biotechnological tools. This time, they are concerned with the CRISPR-Cas9 gene 
editing technology. The prospect of applying this technology to the human germline in 
particular raised concerns amongst scientists, non-scientific experts and the public. Unlike the 
modification of somatic cells, genome editing in germ cells or early embryos affects all cells 
of the developing individual and would then be passed on to future generations – this  raises 25 
special health risks and ethical concerns. In January 2015, life scientists from the USA as well 
as experts from ethics and law convened in Napa Valley to discuss not only the scientific and 
medical, but also the legal and ethical implications of genomic editing in the human germline 
[2]. The Napa meeting – in contrast to the clear recommendations from the Asilomar 
conference – did not result in any specific guidelines. Nevertheless, the Napa group made 30 
several general recommendations for continuing the debate on genome editing in the human 
germline. They suggested, for instance, that the question of how to deal with potential risks 
for patients as well as societal and ethical implications should be discussed in an open and 
interdisciplinary dialogue [2]. They also discouraged pursuing clinical applications in humans 
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while discussions of the medical, societal, environmental and ethical implications were taking 
place [2] so as to provide time to formulate policies for regulation. 
 
 The Asilomar conference and the Napa meeting are two examples of how the scientific 
community can develop recommendations for applying and regulating emerging technologies. 5 
Obviously this involved individuals with varying opinions who had to find a minimal 
consensus for self-regulation that respects basic ethical and legal principles such as 
fundamental human rights. In the following, we will identify opportunities and limits of 
scientific self-regulation based on these two conferences. 
 10 
The pros of self-regulation 
There are some clear advantages to self-regulation. It raises scientists' awareness of their 
work's impact and clarifies their responsibilities. By starting an open and transparent process 
of building consensus, scientists draw public attention to a new development and its potential 
consequences for society and the environment and initiate and inform a public debate that 15 
may be followed by a political process of regulation. It is also beneficial for the scientific 
community itself, as it helps its members to understand the implications of their research and 
potential reactions from the public. Moreover, scientists show that they bear responsibility 
and that they do this in an open and transparent way. 
 20 
The Asilomar conference showed that scientists are capable of reaching a consensus on 
controversial developments more quickly and effectively than a political process would allow, 
especially at the global level, as scientists share a common "language" and culture. In 
addition, they are well qualified to judge the potential risks and side effects of their work. 
Another advantage of the self-regulatory approach is that in light of new technological 25 
developments – which are not well-known among the broader public – scientists have the best 
insight to complement or revise self-regulatory guidelines. 
 
The scientific system inherently has effective instruments and mechanisms for implementing 
guidelines and sanction violations. If journals, conferences, national academies and funding 30 
agencies insist on adherence to rules, it is in the scientists' own interest to comply as they all 
depend on these institutions for their work and careers. When a team of researchers from Sun 
Yat-sen University in Guangdong used the CRISPR-Cas9 technology to modify a disease-
causing gene in human embryos, they restricted their experiment by using non-viable tri-
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pronuclear zygotes [5]. However, even this self-restriction did not go far enough for Nature 
and Science, which both rejected their study [6]. Although the results were eventually 
published elsewhere [5], the initial rejections demonstrate the influence of journals on the 
conduct of research. 
 5 
Although the Asilomar conference and the Napa meeting were driven by scientists from the 
USA, these opportunities suggest that a scientist-led approach to self-regulation could also be 
possible at a global level. The Declaration of Helsinki, first released in 1964 by the "World 
Medical Association"(WMA), is an example of self-regulation in the medical context. It 
defines basic ethical standards for research on human subjects that have been widely 10 
recognized by the medical community and have influenced national regulations in many 
countries. 
Criticism of self-regulation 
Despite these advantages, Asilomar and Napa have both encountered criticism, which reveals 
some disadvantages of consensus building and self-regulation. For instance, critics argued 15 
that the Asilomar conference was too narrowly focused on safety questions, disregarding 
urgent moral issues that may be raised by recombinant DNA technology. Both meetings were 
also criticized for excluding representatives from the general public [7,8]. This criticism 
reveals that consensus of scientists alone cannot be authoritative on controversial moral 
matters, such as the possibility of modifying the human germline, because they do not have 20 
any particular expertise for dealing with such moral and societal issues. In order to address 
moral questions raised by emerging technologies, experts from other fields such as ethics, law 
or social sciences need to be involved to analyse cultural, religious, ideological or emotional 
arguments. Moreover, their professional advice contributes to the decision-making process 
and consensus building. We would therefore call this approach of scientific self-regulation 25 
that includes other experts "self-regulation plus". 
 
What would efficient global regulation in a scientific "self-regulation plus" framework look 
like? The process of reaching a minimal consensus for regulating an emerging technology 
needs to take place within a representative group of scientists. This could be initiated by a 30 
scientific institution that is acknowledged worldwide (such as the WMA for medical 
research). Alternatively, national academies could play a leading role as they already establish 
rules of good scientific practice and codes of conduct. Ideally, this "self-regulatory plus" 
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process should be accompanied by an open debate within the whole scientific community – 
for example through conference talks, open letters, commentaries or scientific papers. 
 
A consensus-building process involving many different national academies could be a 
promising start for developing transnational and international guidelines, which should be 5 
binding for universities and other research institutions and influence the policies of national 
funding institutions. In addition, international scientific journals could publish only those 
articles based on the application of new technology that are in accordance with these 
guidelines. Besides the guidelines outlined by the Helsinki declaration another example of 
self-regulation is the standards of good scientific practice. Any self-regulatory system 10 
ultimately depends on the observance of guidelines and rules by scientists. As the scientific 
community is not a political body and thus has no legal power to govern research and its 
conduct, it may leave room for interpretation concerning what is in compliance and how to 
sanction misconduct. For this reason, the "self-regulatory plus" approach should not be 
understood as an alternative to political regulation, but as a fast, efficient and specific 15 
complement to it. 
 
How then could a "self-regulatory plus" process be complemented by regulation or 
governance at the political and international level? International bodies and intergovernmental 
organs such as the United Nations, UNESCO or the WHO could serve as a framework for 20 
governance approaches, involving expert advice from scientists and/or by establishing 
international bodies with representatives from the scientific community. However, 
negotiations at an international policy level are often slow and inefficient: either the parties 
cannot agree on resulting documents or they reach a minimal consensus that is not sufficiently 
effective. For instance, it was not possible to reach a global consensus on a UN convention to 25 
ban human cloning; it was abandoned in favour of a less binding "UN Declaration on Human 
Cloning" that was only supported by 84 countries [9]. If, however, an agreement on the 
international governmental level should be reached, it will evidently be binding for scientists 
worldwide and might replace a self-regulatory framework (Fig 1). 
 30 
The need for public deliberation 
What role should the public play in the regulation of an emerging technology? If many 
different cultural, societal and religious values are touched upon – as in the case of genome 
editing in the human germline – the public must have a say on how these technologies should 
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be regulated and governed. However, involving the public at a global scale would be 
unmanageable – and values from different cultural and religious backgrounds would make it 
nearly impossible to reach any type of consensus. We therefore suggest that the public should 
be involved at the national level. For at least four reasons, scientific "self-regulation plus" 
must go hand-in-hand with national regulations that consider public concerns. 5 
 
First, consensus building amongst scientists and other exerts lacks democratic legitimacy, as 
the public cannot vote on the decisions themselves or on who represents them during these 
discussions. Second, there is a significant risk that decisions made by an expert body will 
ignore some cultural, historical, religious and other societal values and principles. A 10 
participatory process, in which scientists engage with the public and which leads to 
recommendations for the regulation of the technology in question, could therefore help to 
develop national regulations that consider such issues. This points to a new role that 
academies could play at the national level: not only to represent scientists but also to mediate 
a dialogue between scientists and the general public. 15 
 
Third, public trust and confidence in regulatory regimes is crucial for the successful 
regulation of emerging technologies. As scientists have a professional interest in using and 
developing these technologies, they might be suspected of giving more weight to their own 
preferences than to the common welfare. Thus it is easier to achieve trust in regulation 20 
through a public participatory approach. Fourth, a minimum consensus resulting from a 
scientific "self-regulation plus" process would be a compromise that may not go far enough 
for the public. National regulations can be more restrictive than a minimal consensus among 
scientists, as they incorporate public concerns and requests. 
 25 
The current process initiated by the "International Summit on Human Gene Editing" held in 
Washington, DC, in December 2015, involves some elements of "self-regulation plus" that 
show how the scientific community builds consensus. The organizers of the summit – the 
"National Academy of Sciences" (NAS) and the "National Academy of Medicine" (NAM), 
along with the "Chinese Academy of Sciences" and the "Royal Society" of the UK – invited 30 
internationally-renowned life scientists, bioethicists and legal scientists to explore scientific, 
safety and ethical issues. The attendees concluded that, at the present stage, it would be 
irresponsible to proceed with the clinical use of the CRISPR-Cas9 technology in embryos 
without a better understanding of its risks and benefits, and without a broad agreement 
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(http://www8.nationalacademies.org/onpinews/newsitem.aspx?RecordID=12032015a). An 
experts' committee will therefore meet regularly and develop recommendations on how to 
deal with clinical, ethical, legal, and social implications of genome editing in the human 
germline. 
 5 
The "International Summit on Human Gene Editing" adopts many of the elements that we 
discussed in our own approach to consensus-building and "self-regulation plus". However, the 
summit was organized by only four national academies; we believe that such a process should 
involve academies of more nations. This would not only be a better representation of the 
global scientific community, but there would also be a higher chance that the guidelines will 10 
be implemented by journals, funding agencies, universities and other scientific institutions 
around the globe.  
 
Transparency and trust building 
What specific points must be taken into account for the implementation of "self-regulation 15 
plus" in case of human gene-editing technology? During the forty years since the Asilomar 
conference, the environment in which research takes place has changed profoundly. Debates 
over emerging biotechnologies and their application take place in a public arena accompanied 
by intense media interest. The process initiated by the Asilomar conference cannot therefore 
be transferred on a one-to-one basis to regulate today's technologies. Ethical aspects, which 20 
require the inclusion of ethicists and lawyers, have to be considered at an early stage. Self-
regulation and its guiding principles must also be flexible enough to adapt to rapid 
developments in the global scientific community. As discussed above, "self-regulation plus" 
alone is therefore not sufficient to govern emerging biotechnologies, but it would be suitable 
to initiate the debate on regulations and governance from within the scientific community. 25 
 
Self-regulation in the scientific community only works effectively as long as the public trusts 
scientists to serve the public interest. Thus, it is essential that the consensus building process 
amongst scientists and other experts is transparent. In consequence, this process should be 
covered by the media. Moreover, a public debate should offer the opportunity for scientists to 30 
address public reactions to and concerns about the consensus-building process. There should 
be open and mutual exchange between scientists and the public through open conferences, 
public hearings, the media and the Internet. Another reason why transparency and openness is 
crucial is that the commercialization of science has resulted in an increasing number of 
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conflicts of interest. As stressed by Paul Berg, unlike in the 1970s, many scientists today 
work for private companies [10]. Therefore, scientists have to show convincingly that their 
self-regulation is not driven by third-party interests. 
 
"Self-regulation plus" is a fast, specific and effective way of providing a basic level of 5 
regulation that raises the awareness of these issues, both within the scientific community and 
beyond. For this reason, it is important that the global scientific community assumes 
responsibility for emerging developments such as CRISPR-Cas9 technology by paying 
attention to a self-regulatory approach and refine it to the next level. 
 10 
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Fig 1 | Different approaches for consensus-building and regulation, focusing on the self-
regulation of the scientific community on a global level 
 
